Type 2 Diabetes Mellitus Completed Phase 4 Trials for Rosiglitazone (DB00412)

Also known as: Diabetes Mellitus Non-insulin-dependent / Type-2 Diabetes Mellitus / Diabetes Mellitus Type 2 (T2DM) / Diabetes Mellitus Type-2 / Type 2 Diabetes (T2DM) / Diabetes, Type 2 / Diabetes Mellitus, Type 2 (T2DM) / Diabetes Mellitus´╝îType 2 / Diabetes Type II / Type-II Diabetes Mellitus / Diabetes Mellitus 2 Type / T2DM / Diabetes Mellitus Type II / Type II Diabetes / Diabetes Mellitus, Type 2 / Type 2 Diabetes Mellitus (T2DM) / Diabetes Type Two / Diabetes Mellitus - Type 2 / Diabetes, Type II / Non-Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus. Type 2 / Diabetes Type 2 / Type 2 Diabetes Mellitus (T2D) / Type 2 Diabetes (T2D) / Type II; Diabetes / Type II Diabetes Mellitus / Diabetes Mellitus, Type II / NIDDM / Type-2 Diabetes / Type 2 Diabetes Mellitus(T2DM) / Type 2 Diabetes / Type 2-diabetes / Noninsulin Dependent Diabetes Mellitus, Type II / Diabetes Mellitus Type 2 / Type Two Diabetes Mellitus / T2DM (Type 2 Diabetes Mellitus) / Type-2-diabetes Mellitus / Diabetes mellitus -adult onset / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0029752 (Type 2 Diabetes Mellitus)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00044460Efficacy and Safety In Poorly Controlled Type 2 DiabeticsTreatment
NCT00333723AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide AloneTreatment
NCT00306696Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.Treatment
NCT00306644Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 DiabetesTreatment
NCT00501020Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of MetforminTreatment
NCT00738023Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 DiabetesTreatment
NCT00953498Influence of Glitazones on the Vasodilatory Effect of High-density Lipoprotein (HDL) LipoproteinsTreatment
NCT02526615Effects of Rosiglitazone and Metformin on Metabolism in Type 2 DiabetesTreatment
NCT00121966South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes MellitusTreatment
NCT00123643Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic PatientsPrevention
NCT00358124Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination TherapyTreatment
NCT00373178Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 DiabetesTreatment
NCT00440375Effects of Rosiglitazone on Bone in Postmenopausal Diabetic WomenPrevention
NCT00522470Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels
NCT00679939Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone HealthTreatment
NCT00241605AVANDAMET Versus Metformin For Type 2 Diabetes MellitusTreatment
NCT01045590Glibenclamide (Dose to be Titrated From Starting Dose of 5mg om) Plus Rosiglitazone 4mg om (Increased to 8mg om After 6 Months) and vs Glibenclamide (Dose to be Titrated With Starting Dose of 5mg om) Plus Placebo, Administered to Patients With Type 2 Diabetes MellitusTreatment
NCT00424762Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial TriglycerideTreatment
NCT00386100A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. MetforminTreatment
NCT00571506Effect of Thiazolidinedione Treatment Vascular Risk MarkersTreatment
NCT00329225Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On InsulinTreatment
NCT00306176Rosiglitazone and Exercise in Patients With Type 2 Diabetes MellitusTreatment